Vivani Medical
VANI
32 hedge funds and large institutions have $5.77M invested in Vivani Medical in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
14% more funds holding
Funds holding: 28 → 32 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
1.99% less ownership
Funds ownership: 10.39% → 8.4% (-2%)
14% less capital invested
Capital invested by funds: $6.72M → $5.77M (-$943K)
75% less call options, than puts
Call options by funds: $24K | Put options by funds: $95K
Top Buyers
| 1 |
Jane Street
New York
|
+$72.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$23.8K |
| 3 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$22.9K |
| 4 |
HF
HRT Financial
New York
|
+$18.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$14.6K |
Top Sellers
VANI Hedge Fund Activity: Q4 2024 in Review
32 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2024, worth a combined $5.77M — down 14% from $6.72M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VANI positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $72.3K. The largest seller was Sabby Management, cutting an estimated $1.03M.
- 32 institutional investors held Vivani Medical (VANI) as of Q4 2024, up from 28 in Q3 2024.
- Funds reported $5.77M of Vivani Medical stock for Q4 2024, down 14% quarter-over-quarter.
- 7 funds opened new Vivani Medical positions in Q4 2024 and 3 closed out, a net change of +4 holders.
- The largest Vivani Medical buyer in Q4 2024 was Jane Street, an estimated $72.3K added.
- The largest Vivani Medical seller in Q4 2024 was Sabby Management, an estimated $1.03M sold.
Based on aggregated 13F filings for Q4 2024.